Kraig Biocraft Laboratories Inc (KBLB)

[DimesForShares]

Last year’s approval expired. He is giving himself a new approval based on ‘majority approval’ which means his vote. Thompson could consent to a 1000-to-1 reverse split if he really wanted to.

He may feel constrained by the vote last year, but a 50-to-1 reverse split would make the terms of the public offering more attractive to investors.

NASDAQ does not want to see a newly-listed company fall below the $5 mark right after the opening bell. Not a sign of a successful company.

We will know once the forms have been filled out and submitted to Wyoming, if not before.

I have no idea what all of this will do to the share price except for one outcome that seems improbable to me: we quickly reach $12/share from enthusiasm by big-money investors. If they thought KBLB was a good prospect, they would buy shares on the OTC while they can be purchased cheaply.

If we get a strong short attack on the NASDAQ, watch out below.

GLTA.